Intrust Bank’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $289K | Sell |
2,299
-329
| -13% | -$41.4K | 0.03% | 347 |
|
|
2025
Q1 | $291K | Sell |
2,628
-106
| -4% | -$11.7K | 0.03% | 326 |
|
|
2024
Q4 | $373K | Sell |
2,734
-92
| -3% | -$12.6K | 0.04% | 292 |
|
|
2024
Q3 | $326K | Sell |
2,826
-28
| -1% | -$3.23K | 0.03% | 321 |
|
|
2024
Q2 | $393K | Sell |
2,854
-74
| -3% | -$10.2K | 0.04% | 281 |
|
|
2024
Q1 | $404K | Sell |
2,928
-49
| -2% | -$6.76K | 0.04% | 279 |
|
|
2023
Q4 | $392K | Sell |
2,977
-686
| -19% | -$90.4K | 0.05% | 286 |
|
|
2023
Q3 | $412K | Sell |
3,663
-1,270
| -26% | -$143K | 0.05% | 265 |
|
|
2023
Q2 | $465K | Sell |
4,933
-362
| -7% | -$34.1K | 0.06% | 253 |
|
|
2023
Q1 | $536K | Sell |
5,295
-486
| -8% | -$49.2K | 0.07% | 228 |
|
|
2022
Q4 | $690K | Buy |
5,781
+299
| +5% | +$35.7K | 0.1% | 187 |
|
|
2022
Q3 | $582K | Buy |
5,482
+519
| +10% | +$55.1K | 0.09% | 196 |
|
|
2022
Q2 | $484K | Sell |
4,963
-1,277
| -20% | -$125K | 0.07% | 234 |
|
|
2022
Q1 | $585K | Buy |
6,240
+3,355
| +116% | +$315K | 0.07% | 222 |
|
|
2021
Q4 | $246K | Sell |
2,885
-973
| -25% | -$83K | 0.03% | 358 |
|
|
2021
Q3 | $370K | Buy |
3,858
+400
| +12% | +$38.4K | 0.05% | 279 |
|
|
2021
Q2 | $336K | Buy |
3,458
+1,291
| +60% | +$125K | 0.05% | 287 |
|
|
2021
Q1 | $211K | Buy |
+2,167
| New | +$211K | 0.03% | 360 |
|